253 related articles for article (PubMed ID: 31700623)
21. Pidotimod and Immunological Activation in Individuals Infected with HIV.
Ucciferri C; Falasca K; Reale M; Tamburro M; Auricchio A; Vignale F; Vecchiet J
Curr HIV Res; 2021; 19(3):260-268. PubMed ID: 33430735
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy.
Trabattoni D; Clerici M; Centanni S; Mantero M; Garziano M; Blasi F
Pulm Pharmacol Ther; 2017 Jun; 44():24-29. PubMed ID: 28302543
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.
Esposito S; Garziano M; Rainone V; Trabattoni D; Biasin M; Senatore L; Marchisio P; Rossi M; Principi N; Clerici M
J Transl Med; 2015 Sep; 13():288. PubMed ID: 26335787
[TBL] [Abstract][Full Text] [Related]
24. Pidotimod: a reappraisal.
Riboldi P; Gerosa M; Meroni PL
Int J Immunopathol Pharmacol; 2009; 22(2):255-62. PubMed ID: 19505378
[TBL] [Abstract][Full Text] [Related]
25. Pidotimod may prevent recurrent respiratory infections in children.
Licari A; De Amici M; Nigrisoli S; Marseglia A; Caimmi S; Artusio L; Marseglia GL
Minerva Pediatr; 2014 Oct; 66(5):363-7. PubMed ID: 25253184
[TBL] [Abstract][Full Text] [Related]
26. Whether Immunostimulants Are Effective in Susceptible Children Suffering From Recurrent Respiratory Tract Infections: A Modeling Analysis Based on Literature Aggregate Data.
Zhang W; Huang J; Liu H; Wen X; Zheng Q; Li L
J Clin Pharmacol; 2022 Feb; 62(2):245-253. PubMed ID: 34535904
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
[TBL] [Abstract][Full Text] [Related]
28. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells.
Wang W; Sung N; Gilman-Sachs A; Kwak-Kim J
Front Immunol; 2020; 11():2025. PubMed ID: 32973809
[TBL] [Abstract][Full Text] [Related]
29. Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions.
Larenas-Linnemann D; Rodríguez-Pérez N; Arias-Cruz A; Blandón-Vijil MV; Del Río-Navarro BE; Estrada-Cardona A; Gereda JE; Luna-Pech JA; Navarrete-Rodríguez EM; Onuma-Takane E; Pozo-Beltrán CF; Rojo-Gutiérrez MI
World Allergy Organ J; 2020 Nov; 13(11):100476. PubMed ID: 33072240
[TBL] [Abstract][Full Text] [Related]
30. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
[TBL] [Abstract][Full Text] [Related]
31. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
32. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review.
Bao Y; Cao X
J Autoimmun; 2014 Dec; 55():10-23. PubMed ID: 24794622
[TBL] [Abstract][Full Text] [Related]
33. Circulating CD3
Oba R; Isomura M; Igarashi A; Nagata K
J Immunol Res; 2019; 2019():6720819. PubMed ID: 31205958
[TBL] [Abstract][Full Text] [Related]
34. Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression.
Suzuki K; Kaminuma O; Yang L; Takai T; Mori A; Umezu-Goto M; Ohtomo T; Ohmachi Y; Noda Y; Hirose S; Okumura K; Ogawa H; Takada K; Hirasawa M; Hiroi T; Takaiwa F
Plant Biotechnol J; 2011 Dec; 9(9):982-90. PubMed ID: 21447056
[TBL] [Abstract][Full Text] [Related]
35. Pidotimod enhanced the anti-growth effect of cisplatin on lung cancer in mice via promoting anti-tumor immune response.
Wu T; Cui J; Gao J; Zhou H; Li A; Guo W
Biochem Biophys Res Commun; 2020 Aug; 528(4):678-684. PubMed ID: 32513535
[TBL] [Abstract][Full Text] [Related]
36. Schisandrin B promotes Foxp3
Chiang CY; Chang JH; Chuang HC; Fan CK; Hou TY; Lin CL; Lee YL
Eur J Pharmacol; 2022 Mar; 918():174775. PubMed ID: 35085518
[TBL] [Abstract][Full Text] [Related]
37. Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease.
Berger M; Geng B; Cameron DW; Murphy LM; Schulman ES
Respir Med; 2017 Nov; 132():181-188. PubMed ID: 29229095
[TBL] [Abstract][Full Text] [Related]
38. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures.
Gold MJ; Antignano F; Halim TY; Hirota JA; Blanchet MR; Zaph C; Takei F; McNagny KM
J Allergy Clin Immunol; 2014 Apr; 133(4):1142-8. PubMed ID: 24679471
[TBL] [Abstract][Full Text] [Related]
39. Polybacterial immunomodulator Respivax restores the inductive function of innate immunity in patients with recurrent respiratory infections.
Nikolova M; Stankulova D; Taskov H; Nenkov P; Maximov V; Petrunov B
Int Immunopharmacol; 2009 Apr; 9(4):425-32. PubMed ID: 19186221
[TBL] [Abstract][Full Text] [Related]
40. Involvement of fibrocytes in allergen-induced T cell responses and rhinovirus infections in asthma.
Isgrò M; Bianchetti L; Marini MA; Mattoli S
Biochem Biophys Res Commun; 2013 Aug; 437(3):446-51. PubMed ID: 23831627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
